-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
ARS Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2025.
- ARS Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$40.7M, a 507% decline year-over-year.
- ARS Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $13.5M.
- ARS Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$59.3M, a 47.9% decline from 2022.
- ARS Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$40.1M, a 128% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)